Even though, in 1998, the Home Office granted GW Pharmaceuticals a license to grow cannabis in order to develop cannabinoid-based medicines, Britain is not following suit. Norman Baker, Lib Dem minister of state for crime prevention, called for more liberalised drug laws, and specifically the legalisation of cannabis grown for medicinal use. A coalition spokesman rejected his suggestion outright. And so those seeking cannabis for medicinal purposes must continue to chase it in the same way as recreational users, through the black market.
Liberalised drug laws should be introduced to legalise the widespread use of cannabis to relieve symptoms of certain medical conditions, including the side effects of chemotherapy, the drugs minister Norman Baker will say. Amid concerns that "credible people" are having to break the law to secure the only substance that can help to relieve their condition, Baker is writing to the health secretary, Jeremy Hunt, to call for a review of the medicinal properties of cannabis.
Colombian President Juan Manuel Santos has said he supports the legalisation of marijuana for medical use. He said the measure - which is due to be voted on by Colombian lawmakers - would be a "compassionate response" to pain experienced by people with terminal illnesses. "We look favourably on the initiative on the medical and therapeutic use of marijuana," Santos told a drugs forum in the Colombian capital, Bogota. "It's a way to stop criminals from acting as intermediaries between the patient and a substance that is going to ease their suffering."
Catalonia is drawing up rules to allow the use of marijuana for the treatment of patients suffering from conditions with symptoms such as pain and loss of appetite, the region's health minister Boi Ruiz has said. The move would open the way for the drug to be prescribed to cancer and AIDS patients, among others. The plan was partly designed to stop Barcelona's increasingly popular cannabis clubs from controlling the supply of medical marijuana, Ruiz said.
As Americans continue to embrace pot—as medicine and for recreational use—opponents are turning to a set of academic researchers to claim that policymakers should avoid relaxing restrictions around marijuana. It's too dangerous, risky, and untested, they say. Just as drug company-funded research has become incredibly controversial in recent years, forcing major medical schools and journals to institute strict disclosure requirements, could there be a conflict of interest issue in the pot debate? (See also: The real reason pot is still illegal)